Effects of apoE on neuronal signaling and APP processing in rodent brain
Abstract
We previously reported that primary neuronal cells treated with apolipoprotein E (apoE) or an apoE-derived peptide (EP) increased ERK activation and decreased JNK activation via apoE receptors. Here, we examined if the effects observed in vitro were observed in vivo. Similar to our observations in primary neurons, in vivo we found that injections of 2muM EP into the rat hippocampus increased the levels of ERK activation and decreased JNK activation. However, the time course of these effects was slower in vivo. Immunohistochemical analysis of the tissue showed prominently increased ERK phosphorylation and decreased JNK phosphorylation in neuronal cells throughout the hippocampus, particularly in the CA3 regions. To determine if apoE was endocytosed by neurons, we conjugated fluorescent microspheres with the EP and injected them into the rat hippocampus. After 7 days, the microspheres were present in neurons. We also examined the in vivo effects of apoE on ApoEr2 and APP processing. EP and full-length apoE3 and apoE4 increased C-terminal fragments of ApoEr2 and APP after a single injection, multiple injections, and chronic infusion paradigms. ApoE3 produced higher levels of ApoEr2 and APP C-terminal fragments than apoE4. These results demonstrate that apoE alters ApoEr2 and APP processing in vivo. The increase in ERK activation is consistent with a role for apoE in a neuronal response to stress, and the decrease in JNK activation suggests that apoE may have anti-apoptotic effec…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ApoE4 is a potential enhancer of amyloid peptide production through stimulating APP endocytosis and metabolism in vitro and in vivo.
“ApoE4 has been described as a potential enhancer of amyloid peptide production through stimulating APP endocytosis and metabolism, both in vitro and in vivo [48, 49].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [49]
Cites
Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · see citing works
Pei, J.-J., Braak, H., An, W.-L., Winblad, B., Cowburn, R. F., Iqbal, K., & Grundke-Iqbal, I. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00488-6 · Cited by 247 · see citing works
Narita, M., Bu, G., Holtzman, D. M., & Schwartz, A. L. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020587.x · Cited by 96 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Dourlen, P., Kilinc, D., Malmanche, N., Chapuis, J., & Lambert, J.-C. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02004-0 · Cited by 168 · see citing works
Marzolo, M.-P., & Bu, G. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.10.005 · Cited by 122 · see citing works
Functional Roles of the Interaction of APP and Lipoprotein Receptors
Pohlkamp, T., Wasser, C. R., & Herz, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00054 · Cited by 92 · see citing works
ApoE mimetic peptide decreases Aβ production in vitro and in vivo
Minami, S. S., Cordova, A., Cirrito, J. R., Tesoriero, J. A., Babus, L. W., Davis, G. C., Dakshanamurthy, S., Turner, R. S., Pak, D. T., Rebeck, G. W., et al. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-16 · Cited by 34 · see citing works
Self-citation
- Authors
- Hoe, H.-S., Pocivavsek, A., Dai, H., Chakraborty, G., Harris, D. C., & Rebeck, G. W.
- Affiliations
- Georgetown University (US)
- Corresponding author
- Rebeck, G. William
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 1112
- Issue
- 1
- Pages
- 70-79
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2058786449
- Cited by
- 30
- References
- 3
- Citations by year
- 2022: 1 · 2019: 3 · 2018: 3 · 2017: 1 · 2014: 6 · 2013: 1 · 2012: 2
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AG14473)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- apolipoprotein E, ERK activation, JNK activation, ApoER2, APP processing, APP C-terminal fragments, hippocampus, CA3, neuronal stress response, anti-apoptotic effects, APOE3, APOE ε4, in vivo effects
- MeSH terms
- Animals, Apolipoproteins E, Brain, Dose-Response Relationship, Drug, Endocytosis, Enzyme Activation, Humans, Immunohistochemistry, Neurons, Peptides, Phosphopyruvate Hydratase, Phosphorylation, Time Factors, Blotting, Western, Signal Transduction, Amyloid beta-Protein Precursor, Rats, Sprague-Dawley, Receptors, Lipoprotein, LDL-Receptor Related Proteins, JNK Mitogen-Activated Protein Kinases, Extracellular Signal-Regulated MAP Kinases, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review